Trademark: 79225650
Status Date
Tuesday, November 6, 2018
Registration Number
5598121
Registration Date
Tuesday, November 6, 2018
Filing Date
Wednesday, October 25, 2017
Published for Opposition
Tuesday, August 21, 2018
5 Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of prostate cancer, melanoma, lung cancer, kidney cancer, bladder cancer, ovarian cancer, head and neck cancer, gastric cancer, colorectal cancer, breast cancer, mesothelioma, Hodgkin's lymphoma
Nov 6, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 1, 2019
Final Decision Transaction Processed By Ib
Feb 9, 2019
Final Disposition Notice Sent To Ib
Feb 9, 2019
Final Disposition Processed
Feb 6, 2019
Final Disposition Notice Created, To Be Sent To Ib
Nov 6, 2018
Registered-Principal Register
Aug 21, 2018
Official Gazette Publication Confirmation E-Mailed
Aug 21, 2018
Published For Opposition
Aug 17, 2018
Notification Processed By Ib
Aug 1, 2018
Notification Of Possible Opposition Sent To Ib
Aug 1, 2018
Notification Of Notice Of Publication E-Mailed
Aug 1, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 9, 2018
Approved For Pub - Principal Register
Jul 5, 2018
Teas/Email Correspondence Entered
Jul 4, 2018
Correspondence Received In Law Office
Jul 4, 2018
Teas Response To Office Action Received
Mar 2, 2018
Refusal Processed By Ib
Feb 14, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Feb 14, 2018
Refusal Processed By Mpu
Feb 9, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Feb 9, 2018
Application Filing Receipt Mailed
Feb 8, 2018
Non-Final Action Written
Feb 5, 2018
Assigned To Examiner
Feb 5, 2018
New Application Office Supplied Data Entered
Feb 1, 2018
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
